* Mylan says authorized generic, which will reach pharmacies starting next week, has same drug formulation and device functionality as Epipen auto-injector Sign up here. * Authorized generic for ...
Sen. Patty Murray (D-WA) on Tuesday sent a letter to Mylan CEO Heather Bresch seeking more details, including e-mail communications, on the ways that Mylan attempted to keep Teva’s generic EpiPen from ...
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Auto-Injectors Market Global Forecast by Regions, Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types, ...
HERTFORDSHIRE, England and PITTSBURGH, March 31, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that Meridian Medical Technologies, a Pfizer company and Mylan's manufacturing ...
Mylan is expanding a previously announced overseas recall to now include EpiPen and EpiPen Jr. devices distributed in the U.S. over concerns they may not function properly when needed. Like the ...
The pharmaceuticals company Mylan N.V., under pressure for the price surge of its life-saving EpiPen device, has turned to McDermott Will & Emery in the face of mounting criticism from Congress. The ...
June 29 (Reuters) - Drugmaker Sanofi SASY.PA asked a U.S. judge on Wednesday to curb Mylan's bid to recover litigation costs in an antitrust lawsuit, calling the rival pharmaceutical company's court ...
Mylan Inc. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Teva (Nasdaq: TEVA) that will ...
Drugmaker Mylan announced on Thursday that it will pay $465 million to settle claims relating to the classification of EpiPen auto-injectors and EpiPen Jr. auto-injectors because of allegations of a ...
The FDA warned patients, parents and providers that various EpiPen models could malfunction and spring their needles early. This could happen spontaneously if certain pressures are applied while ...
Mylan beat Sanofi's anti-competitive claims U.S. judge in Kansas weighing dispute June 29 (Reuters) - Drugmaker Sanofi (SASY.PA), opens new tab asked a U.S. judge on Wednesday to curb Mylan's bid to ...